Procter & Gamble is trading 4.1% down at $142.85 after reporting mixed fiscal Q4 2026 results and issuing a cautious outlook for the upcoming year.

  • The company beat earnings per share (EPS) expectations but posted flat organic sales, missing analyst forecasts.
  • Management outlined modest FY 2027 growth targets of 1%–3%, prompting a negative reaction from investors despite broader strength in the consumer staples sector.
  • The cautious guidance for the next fiscal year suggests a potential slowdown in growth momentum compared to previous periods.